Skip to main content
Top
Published in: Medical Microbiology and Immunology 3/2005

01-05-2005 | Original Investigation

Increased susceptibility of male BALB/c mice to coxsackievirus B3-induced myocarditis: role for CD1d

Author: Sally A. Huber

Published in: Medical Microbiology and Immunology | Issue 3/2005

Login to get access

Abstract

BALB/c male mice infected with the H3 variant of coxsackievirus B3 (CVB3) develop fulminant myocarditis. Age-matched female mice show little myocarditis due to decreased virus receptor expression on cardiac cells. TNFα and IL-1β levels were increased in males by 3 days after infection. IFNγ levels increased more slowly throughout the 7-day observation period. CD4+, CD8+, macrophage (Mac3+) and γδ+ cells all accumulated in male hearts, with γδ+ cells showing early (day 3) infiltration. Females also accumulated CD4+ cells, but few of the other cell types. CD4+ cells in male hearts predominately produced IFNγ, indicating a Th1 cell phenotype, whereas CD4+ cells in females produced IL-4, but little IFNγ, indicating a Th2 phenotype. CD1d, a major histocompatibility complex I-like molecule often implicated in innate immunity, was increased in CVB3-infected male but not female cardiocytes both in vivo and in vitro. These results demonstrate that CVB3 infections produce gender-specific differences in both innate and adaptive immunity, which may explain the difference in disease susceptibility.
Literature
1.
go back to reference Badorff C, Lee GH, Lamphear BJ, Martone ME, Campbell KP, Rhoads RE, Knowlton KU (1999) Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nat Med 5:320–326PubMedCrossRef Badorff C, Lee GH, Lamphear BJ, Martone ME, Campbell KP, Rhoads RE, Knowlton KU (1999) Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nat Med 5:320–326PubMedCrossRef
2.
go back to reference Badorff C, Lee GH, Knowlton KU (2000) Enteroviral cardiomyopathy: bad news for the dystrophin-glycoprotein complex. Herz 25:227–232CrossRefPubMed Badorff C, Lee GH, Knowlton KU (2000) Enteroviral cardiomyopathy: bad news for the dystrophin-glycoprotein complex. Herz 25:227–232CrossRefPubMed
3.
4.
go back to reference Bowles NE, Ni J, Marcus F, Towbin JA (2002) The detection of cardiotropic viruses in the myocardium of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 39:892–895CrossRefPubMed Bowles NE, Ni J, Marcus F, Towbin JA (2002) The detection of cardiotropic viruses in the myocardium of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 39:892–895CrossRefPubMed
5.
go back to reference Exley M, Porcelli S, Furman M, Garcia J, Balk S (1998) CD161 (NKR-P1A) costimulation of CD1d-dependent activation of human T cells expressing invariant V alpha 24 J alpha Q T cell receptor alpha chains. J Exp Med 188:867–876CrossRefPubMed Exley M, Porcelli S, Furman M, Garcia J, Balk S (1998) CD161 (NKR-P1A) costimulation of CD1d-dependent activation of human T cells expressing invariant V alpha 24 J alpha Q T cell receptor alpha chains. J Exp Med 188:867–876CrossRefPubMed
6.
go back to reference Exley M, Bigley N, Cheng O, Tahir S, Smiley S, Carter Q, Stills H, Grusby M, Koezuka Y, Taniguchi M, Balk S (2001) CD1d-reactive T-cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virus. J Leukoc Biol 69:713–718PubMed Exley M, Bigley N, Cheng O, Tahir S, Smiley S, Carter Q, Stills H, Grusby M, Koezuka Y, Taniguchi M, Balk S (2001) CD1d-reactive T-cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virus. J Leukoc Biol 69:713–718PubMed
7.
go back to reference Exley MA, He Q, Cheng O, Wang RJ, Cheney CP, Balk SP, Koziel MJ (2002) Cutting edge: Compartmentalization of Th1-like noninvariant CD1d- reactive T cells in hepatitis C virus-infected liver. J Immunol 168:1519–1523PubMed Exley MA, He Q, Cheng O, Wang RJ, Cheney CP, Balk SP, Koziel MJ (2002) Cutting edge: Compartmentalization of Th1-like noninvariant CD1d- reactive T cells in hepatitis C virus-infected liver. J Immunol 168:1519–1523PubMed
8.
go back to reference Fairweather D, Kaya Z, Shellam GR, Lawson CM, Rose NR (2001) From infection to autoimmunity. J Autoimmun 16:175–186CrossRefPubMed Fairweather D, Kaya Z, Shellam GR, Lawson CM, Rose NR (2001) From infection to autoimmunity. J Autoimmun 16:175–186CrossRefPubMed
9.
go back to reference Fearon D, Locksley R (1996) The instructive role of innate immunity in the acquired immune response. Science 277:50–53ADSCrossRef Fearon D, Locksley R (1996) The instructive role of innate immunity in the acquired immune response. Science 277:50–53ADSCrossRef
10.
go back to reference Gulick T, Chung MK, Pieper SJ, Lange LG, Schreiner GF (1989) Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness. Proc Natl Acad Sci USA 86:6753–6757PubMedADSCrossRef Gulick T, Chung MK, Pieper SJ, Lange LG, Schreiner GF (1989) Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness. Proc Natl Acad Sci USA 86:6753–6757PubMedADSCrossRef
11.
go back to reference Henke A, Huber S, Stelzner A, Whitton J (1995) The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis. J Virol 69:6720–6728PubMed Henke A, Huber S, Stelzner A, Whitton J (1995) The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis. J Virol 69:6720–6728PubMed
12.
go back to reference Henke A, Launhardt H, Klement K, Stelzner A, Zell R, Munder T (2000) Apoptosis in coxsackievirus B3-caused diseases: interaction between the capsid protein VP2 and the proapoptotic protein siva. J Virol 74:4284–4890CrossRefPubMed Henke A, Launhardt H, Klement K, Stelzner A, Zell R, Munder T (2000) Apoptosis in coxsackievirus B3-caused diseases: interaction between the capsid protein VP2 and the proapoptotic protein siva. J Virol 74:4284–4890CrossRefPubMed
13.
go back to reference Huber S (2000) T cells expressing the gamma delta T cell receptor induce apoptosis in cardiac myocytes. Cardiovasc Res 45:579–587CrossRefPubMed Huber S (2000) T cells expressing the gamma delta T cell receptor induce apoptosis in cardiac myocytes. Cardiovasc Res 45:579–587CrossRefPubMed
14.
go back to reference Huber S, Lodge P (1984) Coxsackievirus B-3 myocarditis in Balb/c mice. Evidence for autoimmunity to myocyte antigens. Am J Pathol 116:21–29PubMed Huber S, Lodge P (1984) Coxsackievirus B-3 myocarditis in Balb/c mice. Evidence for autoimmunity to myocyte antigens. Am J Pathol 116:21–29PubMed
15.
go back to reference Huber S, Lodge P, Herzum M, Estrin M, Olszewski J (1987) The role of T lymphocytes in the pathogenesis of Coxsackievirus B3 myocarditis. In: Kawai C, Abelmann W, Matsumori A (eds) Cardiomyopathy update 1: Pathogenesis of myocarditis and cardiomyopathy. University of Tokyo Press, Tokyo, p 9 Huber S, Lodge P, Herzum M, Estrin M, Olszewski J (1987) The role of T lymphocytes in the pathogenesis of Coxsackievirus B3 myocarditis. In: Kawai C, Abelmann W, Matsumori A (eds) Cardiomyopathy update 1: Pathogenesis of myocarditis and cardiomyopathy. University of Tokyo Press, Tokyo, p 9
16.
go back to reference Huber S, Mortensen A, Moulton G (1996) Modulation of cytokine expression by CD4+ T cells during coxsackievirus B3 infections of BALB/c mice initiated by cells expressing the gamma delta + T-cell receptor. J Virol 70:3039–3044PubMed Huber S, Mortensen A, Moulton G (1996) Modulation of cytokine expression by CD4+ T cells during coxsackievirus B3 infections of BALB/c mice initiated by cells expressing the gamma delta + T-cell receptor. J Virol 70:3039–3044PubMed
17.
go back to reference Huber S, Graveline D, Newell M, Born W, O’Brien R (2000) V gamma 1+ T cells suppress and V gamma 4+ T cells promote susceptibility to coxsackievirus B3-induced myocarditis in mice. J Immunol 165:4174–4181PubMed Huber S, Graveline D, Newell M, Born W, O’Brien R (2000) V gamma 1+ T cells suppress and V gamma 4+ T cells promote susceptibility to coxsackievirus B3-induced myocarditis in mice. J Immunol 165:4174–4181PubMed
18.
go back to reference Huber S, Graveline D, Born W, O’Brien R (2001) Cytokine production by Vgamma(+)-T-cell subsets is an important factor determining CD4(+)-Th-cell phenotype and susceptibility of BALB/c mice to coxsackievirus B3-induced. J Virol 75:5860–5869CrossRefPubMed Huber S, Graveline D, Born W, O’Brien R (2001) Cytokine production by Vgamma(+)-T-cell subsets is an important factor determining CD4(+)-Th-cell phenotype and susceptibility of BALB/c mice to coxsackievirus B3-induced. J Virol 75:5860–5869CrossRefPubMed
19.
go back to reference Huber S, Shi C, Budd RC (2002) Gammadelta T cells promote a Th1 response during coxsackievirus B3 infection in vivo: role of Fas and Fas ligand. J Virol 76:6487–6494CrossRefPubMed Huber S, Shi C, Budd RC (2002) Gammadelta T cells promote a Th1 response during coxsackievirus B3 infection in vivo: role of Fas and Fas ligand. J Virol 76:6487–6494CrossRefPubMed
20.
go back to reference Kandolf R, Sauter M, Aepinus C, Schnorr JJ, Selinka HC, Klingel K (1999) Mechanisms and consequences of enterovirus persistence in cardiac myocytes and cells of the immune system. Virus Res 62:149–158CrossRefPubMed Kandolf R, Sauter M, Aepinus C, Schnorr JJ, Selinka HC, Klingel K (1999) Mechanisms and consequences of enterovirus persistence in cardiac myocytes and cells of the immune system. Virus Res 62:149–158CrossRefPubMed
21.
go back to reference King C, Mueller Hoenger R, Malo Cleary M, Murali-Krishna K, Ahmed R, King E, Sarvetnick N (2001) Interleukin-4 acts at the locus of the antigen-presenting dendritic cell to counter-regulate cytotoxic CD8+ T-cell responses. Nat Med 7:206–214CrossRefPubMed King C, Mueller Hoenger R, Malo Cleary M, Murali-Krishna K, Ahmed R, King E, Sarvetnick N (2001) Interleukin-4 acts at the locus of the antigen-presenting dendritic cell to counter-regulate cytotoxic CD8+ T-cell responses. Nat Med 7:206–214CrossRefPubMed
22.
go back to reference Knowlton KU, Jeon ES, Berkley N, Wessely R, Huber S (1996) A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3. J Virol 70:7811–7818PubMed Knowlton KU, Jeon ES, Berkley N, Wessely R, Huber S (1996) A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3. J Virol 70:7811–7818PubMed
23.
go back to reference Lane J, Neumann D, Lanfond-Walker A, Herskowitz A, Rose N (1993) Role of IL-1 and tumor necrosis factor in coxsackie virus-induced autoimmune myocarditis. J Immunol 151:1682–1690PubMed Lane J, Neumann D, Lanfond-Walker A, Herskowitz A, Rose N (1993) Role of IL-1 and tumor necrosis factor in coxsackie virus-induced autoimmune myocarditis. J Immunol 151:1682–1690PubMed
24.
go back to reference Lo D, Feng L, Li L, Carson M, Crowley M, Pauza M, Nguyen A, Reilly C (1999) Integrating innate and adaptive immunity in the whole animal. Immunol Rev 169:225–239PubMedCrossRef Lo D, Feng L, Li L, Carson M, Crowley M, Pauza M, Nguyen A, Reilly C (1999) Integrating innate and adaptive immunity in the whole animal. Immunol Rev 169:225–239PubMedCrossRef
25.
go back to reference Lyden D, Huber S (1984) Aggravation of coxsackievirus, group B, type 3-induced myocarditis and increase in cellular immunity to myocyte antigens in pregnant Balb/c mice and animals treated with. Cell Immunol 87:462–472PubMedADSCrossRef Lyden D, Huber S (1984) Aggravation of coxsackievirus, group B, type 3-induced myocarditis and increase in cellular immunity to myocyte antigens in pregnant Balb/c mice and animals treated with. Cell Immunol 87:462–472PubMedADSCrossRef
26.
go back to reference Lyden D, Olszewski J, Feran M, Job L, Huber S (1987) Coxsackievirus B-3-induced myocarditis. Effect of sex steroids on viremia and infectivity of cardiocytes. Am J Pathol 126:432–438PubMed Lyden D, Olszewski J, Feran M, Job L, Huber S (1987) Coxsackievirus B-3-induced myocarditis. Effect of sex steroids on viremia and infectivity of cardiocytes. Am J Pathol 126:432–438PubMed
27.
go back to reference Lyden D, Olszewski J, Huber S (1987) Variation in susceptibility of Balb/c mice to coxsackievirus group B type 3-induced myocarditis with age. Cell Immunol 105:332–339PubMedCrossRef Lyden D, Olszewski J, Huber S (1987) Variation in susceptibility of Balb/c mice to coxsackievirus group B type 3-induced myocarditis with age. Cell Immunol 105:332–339PubMedCrossRef
28.
go back to reference Maisch B, Herzum M, Hufuagel G, Bethge C, Schonian U (1995) Immunosuppressive treatment for myocarditis and dilated cardiomyopathy. Eur Heart J 16 (Suppl O):153–161PubMed Maisch B, Herzum M, Hufuagel G, Bethge C, Schonian U (1995) Immunosuppressive treatment for myocarditis and dilated cardiomyopathy. Eur Heart J 16 (Suppl O):153–161PubMed
29.
go back to reference McManus B, Chow L, Wilson J, Anderson D, Gulizia J, Gauntt C, Klingel K, Beisel K, Kandolf R (1993) Direct myocardial injury by enterovirus: a central role in the evolution of murine myocarditis. Clin Immunol Immunopathol 68:159–169CrossRefPubMed McManus B, Chow L, Wilson J, Anderson D, Gulizia J, Gauntt C, Klingel K, Beisel K, Kandolf R (1993) Direct myocardial injury by enterovirus: a central role in the evolution of murine myocarditis. Clin Immunol Immunopathol 68:159–169CrossRefPubMed
30.
go back to reference Meldrum DR (1998) Tumor necrosis factor in the heart. Am J Physiol 274:R577–595PubMed Meldrum DR (1998) Tumor necrosis factor in the heart. Am J Physiol 274:R577–595PubMed
31.
go back to reference Porcelli S (1995) The CD1 family: a third lineage of antigen-presenting molecules. Adv Immunol 59:1–98PubMedCrossRef Porcelli S (1995) The CD1 family: a third lineage of antigen-presenting molecules. Adv Immunol 59:1–98PubMedCrossRef
32.
go back to reference Rose N, Neumann D, Herskowitz A (1988) Genetics of susceptibility to viral myocarditis in mice. Pathol Immunopathol Res 7:266–278PubMedCrossRef Rose N, Neumann D, Herskowitz A (1988) Genetics of susceptibility to viral myocarditis in mice. Pathol Immunopathol Res 7:266–278PubMedCrossRef
33.
go back to reference Selin LK, Santolucito PA, Pinto AK, Szomolanyi-Tsuda E, Welsh RM (2001) Innate immunity to viruses: control of vaccinia virus infection by gamma delta T cells. J Immunol 166:6784–6794PubMed Selin LK, Santolucito PA, Pinto AK, Szomolanyi-Tsuda E, Welsh RM (2001) Innate immunity to viruses: control of vaccinia virus infection by gamma delta T cells. J Immunol 166:6784–6794PubMed
34.
go back to reference Spada F, Grant E, Peters P, Sugita M, Melian A, Leslie D, Lee H, Donselaar E van, Hanson D, Krensky A, Majdic O, Porcelli S, Morita C, Brenner M (2000) Self-recognition of CD1 by gamma/delta T cells: implications for innate immunity. J Exp Med 191:937–948CrossRefPubMed Spada F, Grant E, Peters P, Sugita M, Melian A, Leslie D, Lee H, Donselaar E van, Hanson D, Krensky A, Majdic O, Porcelli S, Morita C, Brenner M (2000) Self-recognition of CD1 by gamma/delta T cells: implications for innate immunity. J Exp Med 191:937–948CrossRefPubMed
35.
go back to reference Towbin JA (2001) Myocarditis and pericarditis in adolescents. Adolesc Med 12:47–67PubMed Towbin JA (2001) Myocarditis and pericarditis in adolescents. Adolesc Med 12:47–67PubMed
36.
go back to reference Tracy S, Tu Z, Chapman N, Hufnagel G (1995) Genetics of coxsackievirus B3 cardiovirulence. Eur Heart J 16 (Suppl O):15–17PubMed Tracy S, Tu Z, Chapman N, Hufnagel G (1995) Genetics of coxsackievirus B3 cardiovirulence. Eur Heart J 16 (Suppl O):15–17PubMed
37.
go back to reference Van Houten N, Bouchard P, Moraska A, Huber S (1991) Selection of an attenuated Coxsackievirus B3 variant, using a monoclonal antibody reactive to myocyte antigen. J Virol 65:1286–1290PubMed Van Houten N, Bouchard P, Moraska A, Huber S (1991) Selection of an attenuated Coxsackievirus B3 variant, using a monoclonal antibody reactive to myocyte antigen. J Virol 65:1286–1290PubMed
38.
go back to reference Weller A, Simpson K, Herzum M, Van Houten N, Huber S (1989) Coxsackievirus-B3-induced myocarditis: virus receptor antibodies modulate myocarditis. J Immunol 143:1843–1850PubMed Weller A, Simpson K, Herzum M, Van Houten N, Huber S (1989) Coxsackievirus-B3-induced myocarditis: virus receptor antibodies modulate myocarditis. J Immunol 143:1843–1850PubMed
39.
go back to reference Wessely R, Klingel K, Santana LF, Dalton N, Hongo M, Jonathan Lederer W, Kandolf R, Knowlton KU (1998) Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy. J Clin Invest 102:1444–1453PubMedCrossRef Wessely R, Klingel K, Santana LF, Dalton N, Hongo M, Jonathan Lederer W, Kandolf R, Knowlton KU (1998) Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy. J Clin Invest 102:1444–1453PubMedCrossRef
40.
go back to reference Winning T, Gemmell E, Polak B, Savage NW, Seymour GJ, Walsh LJ (1996) Expression of CD1a monocytes cultured with supernatants from periodontally diseased gingival epithelial cells. Oral Dis 2:247–252PubMedCrossRef Winning T, Gemmell E, Polak B, Savage NW, Seymour GJ, Walsh LJ (1996) Expression of CD1a monocytes cultured with supernatants from periodontally diseased gingival epithelial cells. Oral Dis 2:247–252PubMedCrossRef
41.
go back to reference Woodruff J (1980) Viral myocarditis. A review. Am J Pathol 101:425–484PubMed Woodruff J (1980) Viral myocarditis. A review. Am J Pathol 101:425–484PubMed
Metadata
Title
Increased susceptibility of male BALB/c mice to coxsackievirus B3-induced myocarditis: role for CD1d
Author
Sally A. Huber
Publication date
01-05-2005
Publisher
Springer-Verlag
Published in
Medical Microbiology and Immunology / Issue 3/2005
Print ISSN: 0300-8584
Electronic ISSN: 1432-1831
DOI
https://doi.org/10.1007/s00430-004-0221-6

Other articles of this Issue 3/2005

Medical Microbiology and Immunology 3/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.